Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;115(3):390-9.
doi: 10.1016/j.pharmthera.2007.05.011. Epub 2007 Jun 30.

Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis

Affiliations
Review

Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis

Carole A Oskeritzian et al. Pharmacol Ther. 2007 Sep.

Abstract

Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite involved in many cellular processes, acting not only as an extracellular ligand to its specific G protein-coupled receptors, but also as a putative intracellular messenger with yet unidentified targets. Mast cells are tissue-dwelling pivotal early effectors of allergic responses, which produce and secrete S1P that can bind to its receptors present on mast cells to influence their activation and functions. In this review, we will first discuss the current knowledge of S1P production by two isozymes of sphingosine kinase (SphK). Mechanisms of SphK activation will be discussed, with an emphasis on experimental approaches developed to study their differential activation and biological roles in the context of mast cells. The relevance of mast cells in the etiology of allergic disorders, asthma and anaphylaxis is well established. In this review, this concept will be revisited, focusing on the contribution of S1P production and secretion to the symptoms associated with dysregulated inflammatory responses. To conclude, counteracting the proinflammatory effects of S1P could be envisioned as a therapeutic strategy to treat allergic disorders, exacerbated airway inflammation, and anaphylactic reactions, and various options will be discussed, such as the development of pharmacological tools to inhibit SphKs, S1P neutralizing monoclonal antibody, and S1P receptor antagonists.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Sphingolipid metabolites and their effects on mast cell functions
The scheme shows the structures of the bioactive sphingolipid metabolites, sphingosine, sphingosine-1-phosphate, ceramide, and ceramide-1-phosphate and indicates the enzymes responsible for their interconversion. Some important actions regulated by these metabolites in mast cells are indicated.
Figure 2
Figure 2. Actions of S1P in Mast Cell Functions
Crosslinking of FcεRI by antigen causes activation of the tyrosine kinases Lyn and Fyn that in turn stimulate SphK1 and SphK2 leading to formation of S1P. S1P formed by activation of SphK1 can then be exported by ABCC1 transporter to activate S1P receptors on the mast cell surface. S1P1 is important for mast cell migration toward Ag while S1P2 is involved in their degranulation. SphK2 acts internally to regulate calcium homeostasis and PKC, and thus regulates degranulation and release of other lipid mediators and cytokines, probably by regulating the balance between the counteracting sphingolipids, sphingosine and S1P.
Figure 3
Figure 3. Multiple Functions of Mast Cell-Derived S1P in Allergic Inflammation
Secretion of S1P by activated mast cells can promote allergic reactions on a broad scale by activating and recruiting many types of immune cells involved in allergic and inflammatory responses, including eosinophils (Roviezzo et al., 2004), Th2 lymphocytes (Sawicka et al., 2003) and neutrophils. S1P also profoundly affects endothelial cell function and promotes adhesion molecule expression in endothelial cells (Garcia et al., 2001; Lee et al., 1999; Wang et al., 1999; Xia et al., 1998), induces contraction and proliferation of airway smooth muscle cells (Ammit et al., 2001), fibroblast proliferation, and shifts maturing dendritic cell-induced polarization of T cells into a Th2 phenotype (Idzko et al., 2002).

References

    1. Alemany R, Sichelschmidt B, zu Heringdorf DM, Lass H, van Koppen CJ, Jakobs KH. Stimulation of sphingosine-1-phosphate formation by the P2Y(2) receptor in HL-60 cells: Ca(2+) requirement and implication in receptor-mediated Ca(2+) mobilization, but not MAP kinase activation. Mol Pharmacol. 2000;58:491–497. - PubMed
    1. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, Spiegel S, Proia RL. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem. 2004;279:52487–52492. - PubMed
    1. Ammit AJ, Hastie AT, Edsall LC, Hoffman RK, Amrani Y, Krymskaya VP, Kane SA, Peters SP, Penn RB, Spiegel S, Panettieri RA., Jr Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 2001;15:1212–1214. - PubMed
    1. Ancellin N, Colmont C, Su J, Li Q, Mittereder N, Chae SS, Steffansson S, Liau G, Hla T. Extracellular export of sphingosine kinase-1 enzyme: Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem. 2002;277:6667–6675. - PubMed
    1. Berdyshev EV, Gorshkova IA, JG NG, Natarajan V, Hubbard WC. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Anal Biochem. 2005;339:129–136. - PubMed

Publication types

MeSH terms